Manufacturing News of Note—UMass makes lyophilization lab available; Rising pleads to price fixing; U.K. firm doubles space


> The University of Massachusetts Lowell has opened a pilot-scale lyophilization facility accessible to outside users. Story

> The Justice Department will defer prosecuting New Jersey-based Rising Pharmaceuticals for price fixing after the company agreed to pay $3 million and cooperate with authorities. Rising’s parent Aceto, which filed for bankruptcy in February, has accused India’s Aurobindo in a lawsuit of sabotaging its business. Story

> Symbiosis Pharmaceutical Services invested $1.9 million to double the size of its site in Scotland, adding 8,000 square feet of manufacturing and administrative space. Story

> U.K.-based drugmaker Hikma is shipping heparin and other drugs to Civica Rx, the hospital-backed company working to mitigate drug shortages. Release

> CDMO Recipharm has a deal to make the injectable Apta-1 drug candidate for biotech Aptahem. Release


Suggested Articles

CureVac and Tesla are teaming up to produce the German vaccine maker's molecular RNA printers, Tesla CEO Elon Musk tweeted Thursday.

The FDA knocked a California compounding pharmacy facility for a suite of sanitary concerns, including the presence of ants in the plant.

Merck Animal Health will plow $100 million into its DeSoto, Kansas, plant to scale up production of animal vaccines.